-
Something wrong with this record ?
EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis
M. Doubková, J. Švancara, M. Svoboda, M. Šterclová, V. Bartoš, M. Plačková, L. Lacina, M. Žurková, I. Binková, R. Bittenglová, V. Lošťáková, Z. Merta, L. Šišková, R. Tyl, P. Lisá, H. Šuldová, F. Petřík, J. Pšikalová, V. Řihák, T. Snížek, P....
Language English Country England, Great Britain
Document type Journal Article, Meta-Analysis
NLK
Medline Complete (EBSCOhost)
from 2007-07-01
ROAD: Directory of Open Access Scholarly Resources
from 2007
PubMed
28862397
DOI
10.1111/crj.12700
Knihovny.cz E-resources
- MeSH
- Idiopathic Pulmonary Fibrosis diagnosis epidemiology physiopathology MeSH
- Incidence MeSH
- Middle Aged MeSH
- Humans MeSH
- Lung Volume Measurements MeSH
- Survival Rate trends MeSH
- Follow-Up Studies MeSH
- Lung diagnostic imaging physiopathology MeSH
- Tomography, X-Ray Computed methods MeSH
- Prognosis MeSH
- Disease Progression MeSH
- Registries * MeSH
- Retrospective Studies MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Vital Capacity physiology MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Meta-Analysis MeSH
- Geographicals
- Czech Republic epidemiology MeSH
INTRODUCTION: Prognostic factors of idiopathic pulmonary fibrosis (IPF) currently recognized include changes in vital capacity and radiologic findings. However, most of the prognostic studies in IPF are based on clinical studies with preselected IPF populations. Therefore, we decided to analyze the factors influencing IPF prognosis based on the real-practice data from our IPF registry. METHODS: Data of 514 subjects consecutively entered since 2012 into Czech EMPIRE IPF registry were analyzed. RESULTS: Median age of our patient cohort was 67 years (50-82). Median overall survival (OS) of the cohort was 63.1 months. The clinical course of IPF according to FVC (forced vital capacity) changes was stabilized in 32.8% of patients (29.7% according to DLCO [diffuse lung capacity] changes), slowly progressive in 39.5% (45%), rapidly progressive in 23.5% (20.7%); and 1.7% patients had at least one acute exacerbation during follow-up. Deterioration in FVC of ≥10% at month 12 and in DLCO of ≥15% at months 12, 18, and 24 influenced the OS significantly. The fast progressors defined by the DLCO decline rate had higher risk of death compared to those defined by the FVC change over time. In multivariate analysis, age ≥70 years, interstitial HRCT scores ≥3, and change in DLCO of ≥15% at month 12 were confirmed as factors negatively influencing OS. CONCLUSIONS: DLCO changes over time were shown as a better predictor of mortality compared with FVC changes in our study. In our opinion it is necessary to implement the DLCO analysis into clinical trials and routine practice.
Department of Pneumology and Thoracic Surgery Hospital Na Bulovce Prague Czech Republic
Department of Pneumology Faculty of Medicine and Charles University Hradec Králové Czech Republic
Department of Pulmonary Diseases and Tuberculosis Masaryk Hospital Ústí nad Labem Czech Republic
Department of Respiratory Diseases Jihlava Hospital Czech Republic
Department of Respiratory Diseases Nový Jičín Hospital Czech Republic
Department of Respiratory Diseases Pardubice Hospital Czech Republic
Department of Respiratory Diseases Tomáš Baťa Regional Hospital Zlín Czech Republic
Department of Respiratory Diseases Znojmo Hospital Czech Republic
Institute of Biostatistics and Analyses Masaryk University Brno Czech Republic
PneumoAllergolog Department Kromeříž Hospital Czech Republic
Pulmonary Department České Budějovice Hospital Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19001199
- 003
- CZ-PrNML
- 005
- 20231124110609.0
- 007
- ta
- 008
- 190107s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/crj.12700 $2 doi
- 035 __
- $a (PubMed)28862397
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Doubková, Martina $u Department of Phthisiology Pulmonary Diseases and Tuberculosis, Masaryk University Faculty of Medicine and University Hospital, Brno, Czech Republic.
- 245 10
- $a EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis / $c M. Doubková, J. Švancara, M. Svoboda, M. Šterclová, V. Bartoš, M. Plačková, L. Lacina, M. Žurková, I. Binková, R. Bittenglová, V. Lošťáková, Z. Merta, L. Šišková, R. Tyl, P. Lisá, H. Šuldová, F. Petřík, J. Pšikalová, V. Řihák, T. Snížek, P. Reiterer, J. Homolka, P. Musilová, J. Lněnička, P. Palúch, R. Hrdina, R. Králová, H. Hortvíková, J. Strenková, M. Vašáková,
- 520 9_
- $a INTRODUCTION: Prognostic factors of idiopathic pulmonary fibrosis (IPF) currently recognized include changes in vital capacity and radiologic findings. However, most of the prognostic studies in IPF are based on clinical studies with preselected IPF populations. Therefore, we decided to analyze the factors influencing IPF prognosis based on the real-practice data from our IPF registry. METHODS: Data of 514 subjects consecutively entered since 2012 into Czech EMPIRE IPF registry were analyzed. RESULTS: Median age of our patient cohort was 67 years (50-82). Median overall survival (OS) of the cohort was 63.1 months. The clinical course of IPF according to FVC (forced vital capacity) changes was stabilized in 32.8% of patients (29.7% according to DLCO [diffuse lung capacity] changes), slowly progressive in 39.5% (45%), rapidly progressive in 23.5% (20.7%); and 1.7% patients had at least one acute exacerbation during follow-up. Deterioration in FVC of ≥10% at month 12 and in DLCO of ≥15% at months 12, 18, and 24 influenced the OS significantly. The fast progressors defined by the DLCO decline rate had higher risk of death compared to those defined by the FVC change over time. In multivariate analysis, age ≥70 years, interstitial HRCT scores ≥3, and change in DLCO of ≥15% at month 12 were confirmed as factors negatively influencing OS. CONCLUSIONS: DLCO changes over time were shown as a better predictor of mortality compared with FVC changes in our study. In our opinion it is necessary to implement the DLCO analysis into clinical trials and routine practice.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a Česká republika $x epidemiologie $7 D018153
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a idiopatická plicní fibróza $x diagnóza $x epidemiologie $x patofyziologie $7 D054990
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a plíce $x diagnostické zobrazování $x patofyziologie $7 D008168
- 650 _2
- $a měření objemu plic $7 D008176
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prognóza $7 D011379
- 650 12
- $a registrace $7 D012042
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a míra přežití $x trendy $7 D015996
- 650 _2
- $a počítačová rentgenová tomografie $x metody $7 D014057
- 650 _2
- $a vitální kapacita $x fyziologie $7 D014797
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a metaanalýza $7 D017418
- 700 1_
- $a Švancara, Jan, $d 1982- $7 xx0196600 $u Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Svoboda, Michal $u Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Šterclová, Martina $u Department of Respiratory Medicine, First Faculty of Medicine, Charles University, Thomayer Hospital, Prague, Czech Republic.
- 700 1_
- $a Bartoš, Vladimír $u Department of Pneumology, Faculty of Medicine and Charles University, Hradec Králové, Czech Republic.
- 700 1_
- $a Plačková, Martina $u Department of Pneumology, University Hospital in Ostrava, Faculty of Medicine, Pilsen, Charles University, Czech Republic.
- 700 1_
- $a Lacina, Ladislav $u Department of Pneumology and Thoracic Surgery, Hospital Na Bulovce, Prague, Czech Republic.
- 700 1_
- $a Žurková, Monika $u Department of Respiratory Medicine, Faculty of Medicine and Palacky University Hospital Olomouc, Czech Republic.
- 700 1_
- $a Binková, Ilona $u Department of Phthisiology Pulmonary Diseases and Tuberculosis, Masaryk University Faculty of Medicine and University Hospital, Brno, Czech Republic.
- 700 1_
- $a Bittenglová, Radka, $d 1966- $7 xx0110170 $u Department of Respiratory Diseases, Faculty of Medicine and Charles University Hospital Pilsen, Czech Republic.
- 700 1_
- $a Lošťáková, Vladimíra, $d 1959- $7 xx0042188 $u Department of Respiratory Medicine, Faculty of Medicine and Palacky University Hospital Olomouc, Czech Republic.
- 700 1_
- $a Merta, Zdeněk $u Department of Phthisiology Pulmonary Diseases and Tuberculosis, Masaryk University Faculty of Medicine and University Hospital, Brno, Czech Republic.
- 700 1_
- $a Šišková, Lenka $u Department of Respiratory Diseases, Tomáš Baťa Regional Hospital, Zlín, Czech Republic.
- 700 1_
- $a Tyl, Richard $u Department of Respiratory Diseases, Nový Jičín Hospital, Czech Republic.
- 700 1_
- $a Lisá, Pavlína $u Department of Pneumology, Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic. $7 xx0310633
- 700 1_
- $a Šuldová, Hana $u Pulmonary Department, České Budějovice Hospital, Czech Republic. $7 xx0273607
- 700 1_
- $a Petřík, František $u Department of Pneumology, Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Pšikalová, Jana $u PneumoAllergolog Department, Kromeříž Hospital, Czech Republic.
- 700 1_
- $a Řihák, Vladimír $u Department of Respiratory Diseases, Tomáš Baťa Regional Hospital, Zlín, Czech Republic.
- 700 1_
- $a Snížek, Tomáš $u Department of Respiratory Diseases, Jihlava Hospital, Czech Republic.
- 700 1_
- $a Reiterer, Pavel $u Department of Pulmonary Diseases and Tuberculosis, Masaryk Hospital, Ústí nad Labem, Czech Republic.
- 700 1_
- $a Homolka, Jiří $u First Department of Tuberculosis and Respiratory Diseases, General Hospital in Prague and The First Medical Faculty of Charles University, Czech Republic.
- 700 1_
- $a Musilová, Pavlína $u Department of Respiratory Diseases, Jihlava Hospital, Czech Republic.
- 700 1_
- $a Lněnička, Jaroslav $u Department of Pulmonary Diseases and Tuberculosis, Masaryk Hospital, Ústí nad Labem, Czech Republic.
- 700 1_
- $a Palúch, Peter $u Department of Respiratory Medicine, First Faculty of Medicine, Charles University, Thomayer Hospital, Prague, Czech Republic.
- 700 1_
- $a Hrdina, Roman $u Department of Respiratory Diseases, Znojmo Hospital, Czech Republic.
- 700 1_
- $a Králová, Renata $u Department of Respiratory Diseases, Pardubice Hospital, Czech Republic.
- 700 1_
- $a Hortvíková, Hana $u Department of Pneumology, University Hospital in Ostrava, Faculty of Medicine, Pilsen, Charles University, Czech Republic.
- 700 1_
- $a Strenková, Jana $7 xx0235129 $u Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Vašáková, Martina $u Department of Respiratory Medicine, First Faculty of Medicine, Charles University, Thomayer Hospital, Prague, Czech Republic.
- 773 0_
- $w MED00188823 $t The clinical respiratory journal $x 1752-699X $g Roč. 12, č. 4 (2018), s. 1526-1535
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28862397 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20231124110602 $b ABA008
- 999 __
- $a ok $b bmc $g 1365098 $s 1039322
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 12 $c 4 $d 1526-1535 $e 20170926 $i 1752-699X $m The clinical respiratory journal $n Clin Respir J $x MED00188823
- LZP __
- $a Pubmed-20190107
